Monte Rosa Therapeutics shares owned by Casdin Capital
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Casdin Capital
from 13F filings
Historical chart of Casdin Capital investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Casdin Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.9M | 511k | 5.65 |
| 2023-09-30 | $2.4M | 511k | 4.79 |
| 2023-06-30 | $3.5M | 511k | 6.85 |
| 2023-03-31 | $4.0M | 511k | 7.79 |
| 2022-12-31 | $3.9M | 511k | 7.61 |
| 2022-09-30 | $4.2M | 511k | 8.17 |
| 2022-06-30 | $4.9M | 511k | 9.67 |
| 2022-03-31 | $14M | 961k | 14.02 |
| 2021-12-31 | $20M | 961k | 20.42 |
| 2021-09-30 | $21M | 961k | 22.28 |
| 2021-06-30 | $22M | 961k | 22.70 |